Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-023246

Director acquired 76,453 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nark Ted C Director 2024-05-10 Option exercise +76,453 300,771 D
Derivatives
Nark Ted C Director 2024-05-10 Option exercise · Restricted Stock Units −76,453 0 D
Loading xslF345X05/wk-form4_1715719222.xml…